Boehringer Ingelheim has acquired drug discovery and development company Nerio Therapeutics in a $1.3bn deal. Nerio’s small molecules inhibit the protein tyrosine phosphatases N1 and N2...

Eli Lilly and Company has opened the Lilly Seaport Innovation Center (LSC), a research and development (R&D) hub in the Seaport district of Boston, US. The centre is set to progress the...

  Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV) from private equity investor Advent International in a Rs136.3bn...

Agilent Technologies had announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics,...

Lundbeck has entered an agreement to acquire Longboard Pharmaceuticals for an equity value of $2.6 billion, aiming to strengthen its portfolio in the field of neuro-rare conditions. The transaction...

  Modifi Biosciences, a leader in the development of direct DNA modification enabled cancer therapeutics, had announced that the company has been acquired by Merck, known as MSD outside of the...

AbbVie and Aliada Therapeutics had announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology company advancing therapies using a novel blood-brain barrier...